Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kempf

Showing results (381-390 of 415) with videos related to

Pageof 42
Sort By:
Journal of Computer-Aided Molecular Design|February 13, 2007
Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discoveryKent D Stewart, Kevin Steffy, Kevin Harris, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2007
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee modelChih-Ming Chen, Yupeng He, Liangjun Lu, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2008
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivativesDouglas K Hutchinson, Teresa Rosenberg, Larry L Klein, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocketKent D Stewart, Jeffrey R Huth, Teresa I Ng, et al.
Nature Communications|May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Journal of Medicinal Chemistry|January 19, 1996
A novel, picomolar inhibitor of human immunodeficiency virus type 1 proteaseH L Sham, C Zhao, K D Stewart, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, et al.
Plos Neglected Tropical Diseases|March 1, 2019
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activityThomas W von Geldern, Howard E Morton, Rick F Clark, et al.
Journal of Medicinal Chemistry|April 13, 2001
Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells. 1. Selective inhibition of ICAM-1 and E-selectin expressionA O Stewart, P A Bhatia, C M McCarty, et al.
Journal of Medicinal Chemistry|May 1, 2009
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitorsJohn T Randolph, Charles A Flentge, Peggy P Huang, et al.
Pageof 42

Showing results (381-390 of 415) with videos related to

Sort By:
Pageof 42
Journal of Computer-Aided Molecular Design|February 13, 2007
Design and characterization of an engineered gp41 protein from human immunodeficiency virus-1 as a tool for drug discoveryKent D Stewart, Kevin Steffy, Kevin Harris, et al.
Antimicrobial Agents and Chemotherapy|October 3, 2007
Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee modelChih-Ming Chen, Yupeng He, Liangjun Lu, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2008
Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivativesDouglas K Hutchinson, Teresa Rosenberg, Larry L Klein, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
Non-peptide entry inhibitors of HIV-1 that target the gp41 coiled coil pocketKent D Stewart, Jeffrey R Huth, Teresa I Ng, et al.
Nature Communications|May 20, 2020
Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Sylvia Hartmann, Natalie Fadle, et al.
Journal of Medicinal Chemistry|January 19, 1996
A novel, picomolar inhibitor of human immunodeficiency virus type 1 proteaseH L Sham, C Zhao, K D Stewart, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2005
Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patientsAnne-Geneviève Marcelin, Isabelle Cohen-Codar, Martin S King, et al.
Plos Neglected Tropical Diseases|March 1, 2019
Discovery of ABBV-4083, a novel analog of Tylosin A that has potent anti-Wolbachia and anti-filarial activityThomas W von Geldern, Howard E Morton, Rick F Clark, et al.
Journal of Medicinal Chemistry|April 13, 2001
Discovery of inhibitors of cell adhesion molecule expression in human endothelial cells. 1. Selective inhibition of ICAM-1 and E-selectin expressionA O Stewart, P A Bhatia, C M McCarty, et al.
Journal of Medicinal Chemistry|May 1, 2009
Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitorsJohn T Randolph, Charles A Flentge, Peggy P Huang, et al.
Pageof 42